- Company Overview for NAV PHARMA LIMITED (10411803)
- Filing history for NAV PHARMA LIMITED (10411803)
- People for NAV PHARMA LIMITED (10411803)
- More for NAV PHARMA LIMITED (10411803)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
06 Nov 2018 | GAZ2(A) | Final Gazette dissolved via voluntary strike-off | |
06 Sep 2018 | AD01 | Registered office address changed from 84 Raddlebarn Road Selly Oak Birmingham B29 6HH United Kingdom to Corner Oak 1 Homer Road Solihull B91 3QG on 6 September 2018 | |
21 Aug 2018 | GAZ1(A) | First Gazette notice for voluntary strike-off | |
14 Aug 2018 | DS01 | Application to strike the company off the register | |
19 Jul 2018 | AA | Micro company accounts made up to 31 March 2018 | |
16 Jan 2018 | AA01 | Current accounting period extended from 31 October 2017 to 31 March 2018 | |
06 Oct 2017 | PSC01 | Notification of Jagtar Singh Gill as a person with significant control on 5 October 2016 | |
06 Oct 2017 | CS01 | Confirmation statement made on 4 October 2017 with updates | |
06 Oct 2016 | SH01 |
Statement of capital following an allotment of shares on 5 October 2016
|
|
06 Oct 2016 | TM01 | Termination of appointment of Narvinder Singh Nandra as a director on 5 October 2016 | |
06 Oct 2016 | AP01 | Appointment of Mr Jagtar Singh Gill as a director on 5 October 2016 | |
06 Oct 2016 | AP01 | Appointment of Navinder Singh Hayre as a director on 5 October 2016 | |
05 Oct 2016 | NEWINC |
Incorporation
Statement of capital on 2016-10-05
|